Literature DB >> 1979240

Gangliosides prevent MPTP toxicity in mice--an immunocytochemical study.

M Gupta1, J Schwarz, X L Chen, F J Roisen.   

Abstract

The role of gangliosides in preventing neuronal degeneration was examined in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse parkinsonian model. Intraventricular injections of a ganglioside mixture prior to MPTP treatment reduced MPTP's toxicity on tyrosine hydroxylase-positive neurons in the substantia nigra. This raises the interesting possibility that early ganglioside administration may be beneficial in the treatment of neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1979240     DOI: 10.1016/0006-8993(90)91154-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

Review 1.  Therapeutic potential of nerve growth factors in Parkinson's disease.

Authors:  T J Collier; C E Sortwell
Journal:  Drugs Aging       Date:  1999-04       Impact factor: 3.923

Review 2.  A critical role for GM1 ganglioside in the pathophysiology and potential treatment of Parkinson's disease.

Authors:  J S Schneider
Journal:  Glycoconj J       Date:  2021-05-26       Impact factor: 2.916

Review 3.  The Role of Lipids in Parkinson's Disease.

Authors:  Helena Xicoy; Bé Wieringa; Gerard J M Martens
Journal:  Cells       Date:  2019-01-07       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.